Literature DB >> 16675105

RNA regulation and cancer development.

Eva Scholzová1, Radek Malík, Jan Sevcík, Zdenek Kleibl.   

Abstract

Cancer is viewed as a genetic disease. According to the currently accepted model of carcinogenesis, several consequential mutations in oncogenes or tumor suppressor genes are necessary for cancer development. In this model, mutated DNA sequence is transcribed to mRNA that is finally translated into functionally aberrant protein. mRNA is viewed solely as an intermediate between DNA (with 'coding' potential) and protein (with 'executive' function). However, recent findings suggest that (m)RNA is actively regulated by a variety of processes including nonsense-mediated decay, alternative splicing, RNA editing or RNA interference. Moreover, RNA molecules can regulate a variety of cellular functions through interactions with RNA, DNA as well as protein molecules. Although, the precise contribution of RNA molecules by themselves and RNA-regulated processes on cancer development is currently unknown, recent data suggest their important role in carcinogenesis. Here, we summarize recent knowledge on RNA-related processes and discuss their potential role in cancer development.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16675105     DOI: 10.1016/j.canlet.2006.03.021

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  16 in total

1.  Characterization of NOL7 gene point mutations, promoter methylation, and protein expression in cervical cancer.

Authors:  Colleen L Doçi; Tanmayi P Mankame; Alexander Langerman; Kelly R Ostler; Rajani Kanteti; Timothy Best; Kenan Onel; Lucy A Godley; Ravi Salgia; Mark W Lingen
Journal:  Int J Gynecol Pathol       Date:  2012-01       Impact factor: 2.762

2.  Crystal structure of human Edc3 and its functional implications.

Authors:  Sharon H M Ling; Carolyn J Decker; Martin A Walsh; Meipei She; Roy Parker; Haiwei Song
Journal:  Mol Cell Biol       Date:  2008-08-04       Impact factor: 4.272

Review 3.  Epigenetic principles and mechanisms underlying nervous system functions in health and disease.

Authors:  Mark F Mehler
Journal:  Prog Neurobiol       Date:  2008-10-17       Impact factor: 11.685

4.  Loss of function of the candidate tumor suppressor prox1 by RNA mutation in human cancer cells.

Authors:  Meiko Takahashi; Takanobu Yoshimoto; Masayuki Shimoda; Tomoya Kono; Masayuki Koizumi; Shujiro Yazumi; Yutaka Shimada; Ryuichiro Doi; Tsutomu Chiba; Hajime Kubo
Journal:  Neoplasia       Date:  2006-12       Impact factor: 5.715

5.  Age-related prognostic impact of different types of DNMT3A mutations in adults with primary cytogenetically normal acute myeloid leukemia.

Authors:  Guido Marcucci; Klaus H Metzeler; Sebastian Schwind; Heiko Becker; Kati Maharry; Krzysztof Mrózek; Michael D Radmacher; Jessica Kohlschmidt; Deedra Nicolet; Susan P Whitman; Yue-Zhong Wu; Bayard L Powell; Thomas H Carter; Jonathan E Kolitz; Meir Wetzler; Andrew J Carroll; Maria R Baer; Joseph O Moore; Michael A Caligiuri; Richard A Larson; Clara D Bloomfield
Journal:  J Clin Oncol       Date:  2012-01-30       Impact factor: 44.544

6.  Upregulation of the MCL-1S protein variant following dihydroartemisinin treatment induces apoptosis in cholangiocarcinoma cells.

Authors:  Hui Hu; Chunlu Tan; Xubao Liu; Feng Luo; Kezhou Li
Journal:  Oncol Lett       Date:  2015-09-29       Impact factor: 2.967

7.  The effects of p38 gene silencing on breast cancer cells.

Authors:  Fulya Doğaner; Didem Turgut Coşan; Hasan Veysi Güneş; Irfan Değirmenci; Cengiz Bal
Journal:  Mol Biol Rep       Date:  2014-01-28       Impact factor: 2.316

8.  Inhibition of SMG-8, a subunit of SMG-1 kinase, ameliorates nonsense-mediated mRNA decay-exacerbated mutant phenotypes without cytotoxicity.

Authors:  Fusako Usuki; Akio Yamashita; Tadafumi Shiraishi; Atsushi Shiga; Osamu Onodera; Itsuro Higuchi; Shigeo Ohno
Journal:  Proc Natl Acad Sci U S A       Date:  2013-08-27       Impact factor: 11.205

9.  Transcriptome sequencing of malignant pleural mesothelioma tumors.

Authors:  David J Sugarbaker; William G Richards; Gavin J Gordon; Lingsheng Dong; Assunta De Rienzo; Gautam Maulik; Jonathan N Glickman; Lucian R Chirieac; Mor-Li Hartman; Bruce E Taillon; Lei Du; Pascal Bouffard; Stephen F Kingsmore; Neil A Miller; Andrew D Farmer; Roderick V Jensen; Steven R Gullans; Raphael Bueno
Journal:  Proc Natl Acad Sci U S A       Date:  2008-02-26       Impact factor: 11.205

10.  MicroRNA-mediated loss of ADAR1 in metastatic melanoma promotes tumor growth.

Authors:  Yael Nemlich; Eyal Greenberg; Rona Ortenberg; Michal J Besser; Iris Barshack; Jasmine Jacob-Hirsch; Elad Jacoby; Eran Eyal; Ludmila Rivkin; Victor G Prieto; Nitin Chakravarti; Lyn M Duncan; David M Kallenberg; Eitan Galun; Dorothy C Bennett; Ninette Amariglio; Menashe Bar-Eli; Jacob Schachter; Gideon Rechavi; Gal Markel
Journal:  J Clin Invest       Date:  2013-06       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.